Proof of DeSci Episode 5 | Funding the Future: Why JuniperVC Believes in DeSci
May 22, 2025
Michael Luciani is the co-founder of Juniper VC, a venture firm focused on climate biotech and sustainable innovations. In this discussion, he reveals how Juniper sees opportunities in biotech beyond pharmaceuticals, investing in agriculture and materials. Luciani highlights the role of AI in transforming biotech, and the shifting funding landscape through community-driven initiatives like ValleyDAO. Topics such as microbial fertilizers and consumer biotech innovations are also covered, showcasing their potential to engage the public in climate solutions.
AI Snips
Chapters
Transcript
Episode notes
Michael Luciani's Career Journey
- Michael Luciani shares his journey from policy to climate biotech entrepreneurship and investing.
- His co-founder Jenny Kahn's technical expertise gives Juniper VC a competitive edge evaluating biotech startups.
Biotech Beyond Pharma
- Juniper VC sees biotech beyond pharma, focusing equally on food, agriculture, and materials.
- Synthetic biology is at an inflection point driven by cost declines, AI, and automation.
Shifting Climate Biotech Narratives
- Climate biotech investment language shifted towards economics due to political uncertainty in the US.
- Government backing persists but focuses on supply chain resilience and defense rather than direct climate impact.